Urovant Sciences Competitors and Similar CompaniesClear all
Pfizer's competitors and similar companies include Takeda and Kymera Therapeutics.
 Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. | |
Founding Date | Founding Date 1849 | Founding Date 1781 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Watertown, US HQ Cambridge, US | |
Employees | Employees 81,0008% decrease | Employees 47,4554% decrease | Employees 207 |
Valuation ($) | Valuation ($) 163.9 b | Valuation ($) 43.7 b | Valuation ($) 3.1 b |
Financial | |||
Revenue (est.) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $39.2m (FY, 2025) |
Cost of goods | Cost of goods $16.1b (FY, 2025) | Cost of goods ¥818.8b (FY, 2025) | Cost of goods $39.2m (FY, 2025) |
Gross profit | Gross profit $46.5b (FY, 2025) | Gross profit ¥3.8t (FY, 2025) | Gross profit N/A |
Net income | Net income $7.8b (FY, 2025) | Net income ¥108.1b (FY, 2025) | Net income ($311.4m) (FY, 2025) |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 51 (FY, 2024) | Phase I Trials Products 2 (May, 2025) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 27 (FY, 2024) | Phase II Trials Products 10 (May, 2025) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products 17 (May, 2025) | Phase III Trials Products N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised $ 197m |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyKymera Therapeutics
HQ
Watertown, US
Employees
207
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
View company